July 16, 2019
Results: Arbutus Biopharma’s AB-506 is a potent capsid inhibitor
Arbutus Biopharma’s AB-506 is a potent oral capsid inhibitor, preliminary results from testing have shown, the company said Monday.
Pharmaceuticals, Biotechnology and Life Sciences
Arbutus Biopharma’s AB-506 is a potent oral capsid inhibitor, preliminary results from testing have shown, the company said Monday.